SEC EDGAR Filing Information

Form 10-K -- Annual report [Section 13 and 15(d), not S-K Item 405]

Period of Report: 2007-12-31
Filing Date Changed: 2008-02-29
Documents: 6

SEC Accession No.
0001193125-08-043939
Filing date: 2008-02-29
Accepted: 2008-02-29 17:25:36

Table of submitted documents:

Seq	Type	Document	Size	Description
1	10-K	d10k.htm	3057917	FORM 10-K FOR YEAR ENDED DECEMBER 31, 2007
2	EX-21	dex21.htm	9581	SUBSIDIARIES OF THE REGISTRANT
3	EX-31.1	dex311.htm	10635	CERTIFICATION OF CHIEF EXECUTIVE OFFICER
4	EX-31.2	dex312.htm	10779	CERTIFICATION OF CHIEF FINANCIAL OFFICER
5	EX-32.1	dex321.htm	3744	CERTIFICATION OF CHIEF EXECUTIVE OFFICER
6	EX-32.2	dex322.htm	3765	CERTIFICATION OF CHIEF FINANCIAL OFFICER

		0001193125-08-043939.txt	3098485	Complete submission text file

Filer Information:

US ONCOLOGY INC (Filer) (0000943061)
IRS No.: 841213501 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26190 | Film No.: 08657144
SIC: 8093 Services-Specialty Outpatient Facilities, NEC

Assistant Director 1

Business Address
16825 NORTHCHASE DR
STE 1300
HOUSTON TX 77060
2818732674

Mailing Address

US Oncology Holdings, Inc. (Filer) (0001333191)
IRS No.: 200873619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-126922 | Film No.: 08657143
SIC: 8060 Services-Hospitals

Assistant Director 1

Business Address
16825 NORTHCHASE DRIVE, SUITE 1300
HOUSTON TX 77060
(832) 601-8766

Mailing Address
16825 NORTHCHASE DRIVE, SUITE 1300
HOUSTON TX 77060